1,2,3-Triazole-Containing 1,5,6,7-Tetrahydro-4H-indazol-4-ones and 6,7-Dihydrobenzo[d]isoxazol-4(5H)-ones: Synthesis and Biological Activity

被引:0
作者
Khlebnicova, T. S. [1 ]
Zinovich, V. G. [1 ]
Piven, Yu. A. [1 ]
Baranovsky, A. V. [1 ]
Lakhvich, F. A. [1 ]
Trifonov, R. E. [2 ]
Golubeva, Yu. A. [3 ,4 ]
Klyushova, L. S. [4 ]
Lider, E. V. [3 ]
机构
[1] Natl Acad Sci Belarus, Inst Bioorgan Chem, Minsk 220084, BELARUS
[2] Tech Univ, St Petersburg State Inst Technol, St Petersburg 190013, Russia
[3] Russian Acad Sci, AV Nikolaev Inst Inorgan Chem, Siberian Branch, Novosibirsk 630090, Russia
[4] Fed Res Ctr Fundamental & Translat Med, Inst Mol Biol & Biophys, Novosibirsk 630060, Russia
基金
俄罗斯基础研究基金会;
关键词
1; 5; 6; 7-tetrahydro-4H-indazol-4-ones; 7-dihydrobenzo[d]isoxazol-4(5H)-ones; 2; 3-triazoles; 2-[(1H-1; 3-triazol-1-yl)acetyl]cyclohexane-1; 3-diones; cytotoxic activity; cytostatic activity; DERIVATIVES; INDAZOLE; TRIAZOLE;
D O I
10.1134/S1070363223020068
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Triazole-containing 1,5,6,7-tetrahydro-4H-indazol-4-ones and 6,7-dihydrobenzo[d]isoxazol-4(5H)-ones were synthesized by cyclocondensation of 2-[(1H-1,2,3-triazol-1-yl)acetyl]cyclohexane-1,3-diones with phenylhydrazine (4-fluorophenylhydrazine) or hydroxylamine, respectively. Structure and composition of the obtained compounds were confirmed by H-1, C-13, F-19 NMR spectroscopy methods and by data of elemental analysis. Cytotoxic and cytostatic activities of the series of obtained compounds were investigated in vitro against human hepatocellular carcinoma cells HepG2, mammary adenocarcinoma cells MCF-7, and laryngeal cancer cells Hep2.
引用
收藏
页码:268 / 277
页数:10
相关论文
共 30 条
[1]   1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview [J].
Bozorov, Khurshed ;
Zhao, Jiangyu ;
Aisa, Haji A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (16) :3511-3531
[2]   Indazole scaffold: a generalist for marketed and clinical drugs [J].
Cao, Yaquan ;
Luo, Chunying ;
Yang, Pu ;
Li, Pan ;
Wu, Chunli .
MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (03) :501-518
[3]   Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agents [J].
Dheer, Divya ;
Behera, Chittaranjan ;
Singh, Davinder ;
Abdullaha, Mohd ;
Chashoo, Gousia ;
Bharate, Sandip B. ;
Gupta, Prem N. ;
Shankar, Ravi .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 207
[4]   Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers [J].
Gutierrez, Martin ;
Guo, Robin ;
Giaccone, Giuseppe ;
Liu, Stephen V. ;
Hao, Zhonglin ;
Hilton, Christie ;
Hinson, James M., Jr. ;
Kris, Mark G. ;
Orlemans, Everardus Otto ;
Drilon, Alexander .
LUNG CANCER, 2021, 162 :23-28
[5]   Synthesis and Cytotoxic Activity of Tetrazole-Containing 1,5,6,7-Tetrahydro-4H-indazol-4-ones [J].
Khlebnicova, T. S. ;
Zinovich, V. G. ;
Piven, Yu A. ;
Baranovsky, A., V ;
Lakhvich, F. A. ;
Trifonov, R. E. ;
Golubeva, Yu A. ;
Lider, E., V .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (03) :359-366
[6]   Synthesis of 2-(Tetrazolylacetyl)cyclohexane-1,3-diones [J].
Khlebnicova, T. S. ;
Zinovich, V. G. ;
Piven, Yu A. ;
Baranovsky, A., V ;
Lakhvich, F. A. ;
Trifonov, R. E. .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2021, 91 (08) :1438-1443
[7]   Regioselective Synthesis of Polyfluoroalkyl Substituted 6,7-Dihydrobenzisoxazolones [J].
Khlebnicova, Tatyana S. ;
Piven', Yurii A. ;
Isakova, Veronica G. ;
Baranovsky, Alexander V. ;
Lakhvich, Fedor A. ;
Sorochinsky, Alexander E. ;
Gerus, Igor I. .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2018, 55 (07) :1791-1797
[8]   Synthesis and Spectroscopic Investigation of the New Polyfluoroalkyl-containing Indazolones [J].
Khlebnikova, T. S. ;
Isakova, V. G. ;
Baranovskii, A. V. ;
Lakhvich, F. A. .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2008, 78 (10) :1954-1963
[9]  
Khlebnikova TS, 2017, CHEM HETEROCYCL COM+, V53, P1254, DOI [10.1007/4047, 10.1007/s10593-018-2198-x]
[10]   Triazole analogues as potential pharmacological agents: a brief review [J].
Kumar, Sachin ;
Khokra, Sukhbir Lal ;
Yadav, Akash .
FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 7 (01)